{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T08:37:46Z","timestamp":1792831066284,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2022-NR069995"],"award-info":[{"award-number":["RS-2022-NR069995"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-202625492909"],"award-info":[{"award-number":["NRF-202625492909"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2020-NR049589"],"award-info":[{"award-number":["RS-2020-NR049589"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2020R1C1C1008148"],"award-info":[{"award-number":["NRF-2020R1C1C1008148"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bioorg.2026.110592","type":"journal-article","created":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T22:09:38Z","timestamp":1790546978000},"page":"110592","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Tetracyclic pyrazinocarbazole derivatives as YAP\u2013TEAD pathway inhibitors with activity in a melanoma lung colonization model"],"prefix":"10.1016","volume":"183","author":[{"given":"Xiang","family":"Fei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanha","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaelin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyesun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hien Thi Thu","family":"Do","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangil","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seongwon","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soonsil","family":"Hyun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang Mo","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inmoo","family":"Rhee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Yong","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.110592_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.113926","article-title":"The Hippo signaling pathway in development and regeneration","volume":"43","author":"Zhong","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.bioorg.2026.110592_bb0010","doi-asserted-by":"crossref","unstructured":"Fu, M. et al. The Hippo signalling pathway and its implications in human health and diseases. Signal Transduct. Target. Ther. vol. 7 Preprint at Doi: https:\/\/doi.org\/10.1038\/s41392-022-01191-9 (2022).","DOI":"10.1038\/s41392-022-01191-9"},{"key":"10.1016\/j.bioorg.2026.110592_bb0015","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10040115","article-title":"YAP\/TAZ activation as a target for treating metastatic cancer","volume":"10","author":"Warren","year":"2018","journal-title":"Cancers"},{"key":"10.1016\/j.bioorg.2026.110592_bb0020","unstructured":"Ghaboura, N. Unraveling the Hippo pathway: YAP\/TAZ as central players in cancer metastasis and drug resistance. EXCLI J. vol. 24 612\u2013637 Preprint at Doi: 10.17179\/excli2025-8351 (2025)."},{"key":"10.1016\/j.bioorg.2026.110592_bb0025","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-023-02704-2","article-title":"New insights into the ambivalent role of YAP\/TAZ in human cancers","volume":"42","author":"Luo","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bioorg.2026.110592_bb0030","doi-asserted-by":"crossref","unstructured":"Battina, R., Rahhal, R., Wellstein, A., Riegel, A. T. & Sharif, G. M. Targeting TEAD in cancer. Front. Oncol. vol. 15 Preprint at Doi: https:\/\/doi.org\/10.3389\/fonc.2025.1692512 (2025).","DOI":"10.3389\/fonc.2025.1692512"},{"key":"10.1016\/j.bioorg.2026.110592_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15235497","article-title":"New insights into YAP\/TAZ-TEAD-mediated gene regulation and biological processes in cancer","volume":"15","author":"Zhao","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.bioorg.2026.110592_bb0040","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1101\/gad.1664408","article-title":"TEAD mediates YAP-dependent gene induction and growth control","volume":"22","author":"Zhao","year":"2008","journal-title":"Genes Dev."},{"key":"10.1016\/j.bioorg.2026.110592_bb0045","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1038\/ncb3216","article-title":"Genome-wide association between YAP\/TAZ\/TEAD and AP-1 at enhancers drives oncogenic growth","volume":"17","author":"Zanconato","year":"2015","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bioorg.2026.110592_bb0050","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1042\/CS20201474","article-title":"The Hippo pathway in cancer: YAP\/TAZ and TEAD as therapeutic targets in cancer","volume":"136","author":"Cunningham","year":"2022","journal-title":"Clin. Sci."},{"key":"10.1016\/j.bioorg.2026.110592_bb0055","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/s43018-024-00754-9","article-title":"Direct and selective pharmacological disruption of the YAP\u2013TEAD interface by IAG933 inhibits Hippo-dependent and RAS\u2013MAPK-altered cancers","volume":"5","author":"Chapeau","year":"2024","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.bioorg.2026.110592_bb0060","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1101\/gad.1865810","article-title":"Structural insights into the YAP and TEAD complex","volume":"24","author":"Li","year":"2010","journal-title":"Genes Dev."},{"key":"10.1016\/j.bioorg.2026.110592_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.104099","article-title":"Long-range structural preformation in yes-associated protein precedes encounter complex formation with TEAD","volume":"25","author":"Feichtinger","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.bioorg.2026.110592_bb0070","article-title":"Hot spot analysis of yap-tead protein-protein interaction using the fragment molecular orbital method and its application for inhibitor discovery","volume":"13","author":"Kim","year":"2021","journal-title":"Cancers (Basel)."},{"key":"10.1016\/j.bioorg.2026.110592_bb0075","doi-asserted-by":"crossref","unstructured":"Zhao, B., Pobbati, A. V., Rubin, B. P. & Stauffer, S. Leveraging hot spots of TEAD\u2013coregulator interactions in the design of direct small molecule protein-protein interaction disruptors targeting Hippo pathway signaling. Pharmaceuticals vol. 16 Preprint at Doi: https:\/\/doi.org\/10.3390\/ph16040583 (2023).","DOI":"10.3390\/ph16040583"},{"key":"10.1016\/j.bioorg.2026.110592_bb0080","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nchembio.2036","article-title":"Autopalmitoylation of TEAD proteins regulates transcriptional output of the Hippo pathway","volume":"12","author":"Chan","year":"2016","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bioorg.2026.110592_bb0085","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.str.2015.11.005","article-title":"Palmitoylation of TEAD transcription factors is required for their stability and function in Hippo pathway Signaling","volume":"24","author":"Noland","year":"2016","journal-title":"Structure"},{"key":"10.1016\/j.bioorg.2026.110592_bb0090","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-34559-0","article-title":"Pharmacological blockade of TEAD\u2013YAP reveals its therapeutic limitation in cancer cells","volume":"13","author":"Sun","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2026.110592_bb0095","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.80210","article-title":"Discovery of a new class of reversible TEA domain transcription factor inhibitors with a novel binding mode","volume":"11","author":"Hu","year":"2022","journal-title":"Elife"},{"key":"10.1016\/j.bioorg.2026.110592_bb0100","article-title":"The novel potent TEAD inhibitor, K-975, inhibits YAP1\/ TAZ-TEAD protein-protein interactions and exerts an anti-tumor effect on malignant pleural mesothelioma","volume":"10","author":"Kaneda","year":"2020","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.bioorg.2026.110592_bb0105","doi-asserted-by":"crossref","first-page":"4281","DOI":"10.1038\/s41591-025-04029-3","article-title":"YAP\/TEAD inhibitor VT3989 in solid tumors: a phase 1\/2 trial","volume":"31","author":"Yap","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.bioorg.2026.110592_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10050140","article-title":"Toward the discovery of a novel class of YAP-TEAD interaction inhibitors by virtual screening approach targeting YAP-TEAD protein-protein interface","volume":"10","author":"Gibault","year":"2018","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bioorg.2026.110592_bb0115","doi-asserted-by":"crossref","first-page":"462","DOI":"10.15252\/embj.201592081","article-title":"Actin remodeling confers BRAF inhibitor resistance to melanoma cells through YAP \/ TAZ activation","volume":"35","author":"Kim","year":"2016","journal-title":"EMBO J."},{"key":"10.1016\/j.bioorg.2026.110592_bb0120","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/ng.3218","article-title":"The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies","volume":"47","author":"Lin","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bioorg.2026.110592_bb0125","doi-asserted-by":"crossref","first-page":"3953","DOI":"10.1038\/s41388-022-02400-z","article-title":"Suppression of heparan sulfation re-sensitizes YAP1-driven melanoma to MAPK pathway inhibitors","volume":"41","author":"Dieter","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.bioorg.2026.110592_bb0130","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1158\/2326-6066.CIR-17-0320","article-title":"YAP-induced PD-L1 expression drives immune evasion in BRAFi-resistant melanoma","volume":"6","author":"Kim","year":"2018","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.bioorg.2026.110592_bb0135","doi-asserted-by":"crossref","first-page":"154","DOI":"10.4062\/biomolther.2025.224","article-title":"Targeting YAP-TEAD interaction with honokiol to inhibit melanoma progression and metastasis","volume":"34","author":"Lee","year":"2026","journal-title":"Biomol. Ther. (Seoul)."},{"key":"10.1016\/j.bioorg.2026.110592_bb0140","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-64682-7","article-title":"Targeting TAZ-TEAD in minimal residual disease enhances the duration of targeted therapy in melanoma models","volume":"16","author":"Ott","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2026.110592_bb0145","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1021\/acs.jmedchem.8b01402","article-title":"Antiproliferative and antimigratory effects of a novel YAP-TEAD interaction inhibitor identified using in silico molecular docking","volume":"62","author":"Smith","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110592_bb0150","series-title":"Process for the preparation of pirlindole hydrochloride","author":"Ferrari","year":"2002"},{"key":"10.1016\/j.bioorg.2026.110592_bb0155","doi-asserted-by":"crossref","first-page":"6237","DOI":"10.1016\/S0040-4039(00)01038-8","article-title":"Practical methylation of aryl halides by Suzuki\u2013Miyaura coupling","volume":"41","author":"Gray","year":"2000","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.bioorg.2026.110592_bb0160","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1021\/acsomega.9b03226","article-title":"Facile hydrogenative deprotection of N-benzyl groups using a mixed catalyst of palladium and niobic acid-on-carbon","volume":"5","author":"Yamamoto","year":"2020","journal-title":"ACS Omega"},{"key":"10.1016\/j.bioorg.2026.110592_bb0165","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1021\/acschembio.5b00753","article-title":"NanoLuc complementation reporter optimized for accurate measurement of protein interactions in cells","volume":"11","author":"Dixon","year":"2016","journal-title":"ACS Chem. Biol."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826011284?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826011284?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T08:02:50Z","timestamp":1792828970000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826011284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":33,"alternative-id":["S0045206826011284"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110592","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tetracyclic pyrazinocarbazole derivatives as YAP\u2013TEAD pathway inhibitors with activity in a melanoma lung colonization model","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110592","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110592"}}